{"schema_version":"1","generated_at":"2026-10-31T04:44:08.686Z","data_as_of":null,"url":"https://www.findmykol.com/kol/julie-chang","json_url":"https://www.findmykol.com/kol/julie-chang/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"julie-chang","name":"Julie Chang","credential":"MD","specialty":"Hematology","specialty_raw":"Hematology","therapeutic_area":"Hematology","therapeutic_areas":["Hematology"],"city":"Madison","state":"WI","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1679524078"},"summary":"Julie Chang is a Hematology physician. ClinicalTrials.gov lists 4 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Hematology"]},"scholarship":{"note":"Research metrics are not shown for this record: either no confident publication match for this name, or more than one clinician shares the matched author record."},"trials":{"count":4,"shown":3,"withheld":1,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT03311126","title":"Bendamustine + Obinutuzumab Induction With Obinutuzumab Maintenance in Untreated Mantle Cell Lymphoma","phase":"PHASE2","status":"TERMINATED","role":"Overall official","sponsor":"University of Wisconsin, Madison","source_url":"https://clinicaltrials.gov/study/NCT03311126","trial_url":"https://www.findmykol.com/trial/NCT03311126"},{"nct":"NCT01754870","title":"Phase II Study of Bendamustine and Rituximab Induction Chemoimmunotherapy Followed by Maintenance Rituximab (Rituxan®) and Lenalidomide (Revlimid®) in Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)","phase":"PHASE2","status":"WITHDRAWN","role":"Overall official","sponsor":"University of Wisconsin, Madison","source_url":"https://clinicaltrials.gov/study/NCT01754870","trial_url":"https://www.findmykol.com/trial/NCT01754870"},{"nct":"NCT01754857","title":"Bendamustine and Rituximab Induction Therapy and Maintenance Rituximab and Lenalidomide in Previously Untreated CLL/SLL","phase":"PHASE2","status":"COMPLETED","role":"Overall official","sponsor":"University of Wisconsin, Madison","source_url":"https://clinicaltrials.gov/study/NCT01754857","trial_url":"https://www.findmykol.com/trial/NCT01754857"}],"source":"trials"},"payments":{"company_count":10,"program_years":{"first":2021,"last":null},"rows_total":14,"shown":3,"withheld":11,"rows":[{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2025,"amount_usd":2870,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1679524078"},{"payer":"Incyte Corporation","program_year":2025,"amount_usd":2055,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1679524078"},{"payer":"ADC THERAPEUTICS AMERICA, INC.","program_year":2025,"amount_usd":100.38,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1679524078"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1679524078","source":"payments"},"prescribing":{"data_year":2024,"areas_total":8,"areas_shown":3,"areas":[{"area":"Dermatology","share_pct":33.8,"classes_total":1,"classes":[{"class":"Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor","setting":"prescribed","share_pct":33.8,"drugs":[{"name":"Acyclovir","share_pct":100}],"max_beneficiaries":60}]},{"area":"Metabolism & gastrointestinal","share_pct":21.1,"classes_total":5,"classes":[{"class":"Proton pump inhibitor","setting":"prescribed","share_pct":5.7,"drugs":[{"name":"Omeprazole","share_pct":77.8},{"name":"Pantoprazole Sodium","share_pct":22.2}],"max_beneficiaries":null},{"class":"H2 blocker","setting":"prescribed","share_pct":5.2,"drugs":[{"name":"Famotidine","share_pct":100}],"max_beneficiaries":20}]},{"area":"Cancer & immunology","share_pct":18.5,"classes_total":2,"classes":[{"class":"Kinase inhibitor","setting":"prescribed","share_pct":13.8,"drugs":[{"name":"Brukinsa","share_pct":47.7},{"name":"Calquence","share_pct":19.2},{"name":"Jaypirca","share_pct":19.2},{"name":"Imbruvica","share_pct":13.8}],"max_beneficiaries":null},{"class":"BCL-2 Inhibitor","setting":"prescribed","share_pct":4.7,"drugs":[{"name":"Venclexta","share_pct":100}],"max_beneficiaries":15}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":24.8,"facility_pct":75.2},"source":"medicare"},"contact":{"address_1":"9242 BEAR CLAW WAY","city":"Madison","state":"WI","zip":"537172734","phone":"608-827-9665","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1679524078","source":"identity"},"similar":[{"name":"Joseph Antin","slug":"joseph-antin","institution":"Harvard University","specialty":"Hematology","url":"https://www.findmykol.com/kol/joseph-antin","json_url":"https://www.findmykol.com/kol/joseph-antin/profile.json"},{"name":"Scott Kaufmann","slug":"scott-kaufmann","institution":"Mayo Clinic College of Medicine","specialty":"Hematology","url":"https://www.findmykol.com/kol/scott-kaufmann","json_url":"https://www.findmykol.com/kol/scott-kaufmann/profile.json"},{"name":"Jeffrey Miller","slug":"jeffrey-miller","institution":"University of Minnesota Medical School","specialty":"Hematology","url":"https://www.findmykol.com/kol/jeffrey-miller","json_url":"https://www.findmykol.com/kol/jeffrey-miller/profile.json"},{"name":"Ruben Mesa","slug":"ruben-mesa","institution":"Atrium Health Wake Forest Baptist Comprehensive Cancer Center","specialty":"Hematology","url":"https://www.findmykol.com/kol/ruben-mesa","json_url":"https://www.findmykol.com/kol/ruben-mesa/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":1,"payments":11}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2025-10-21","provider_certified":"2025-10-21","collected_at":"2026-10-31T00:00:00.000Z"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}